NCT06495164 2025-11-25A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast CancerPfizerActive not recruiting1 enrolled
NCT06075758 2025-01-14A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast CancerNovartisRecruiting550 enrolled
NCT05569187 2022-11-08Ribociclib in Combination With Non-steroidal Aromatase Inhibitors in Patients With Advanced Breast CancerNovartisCompleted76 enrolled
NCT05153135 2021-12-21Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 InhibitorsNovartisCompleted4,320 enrolled